In India, one in five patients suffering sudden cardiac arrest is less than 40 years of age.(Pexels/Towfiqu Barbhuiya) A ...

The following is a summary of “Impact of Ablation on AF burden and symptoms in HCM,” published in the October 2024 issue of ...

Cardiogenetics plays a crucial role in understanding hereditary factors in cardiovascular diseases (CVDs). Genetic screening ...

Researchers from Affinia Therapeutics Inc. have described the development and preclinical evaluation of a new AAV-based gene ...

The Icahn School of Medicine at Mount Sinai will award its 2024 Maria I. New International Prize for Biomedical Research to ...

A research team from the Mayo Clinic externally validated an AI electrocardiography algorithm that detects hypertrophic ...

ISCCON 2024 focuses on sudden cardiac death in India, emphasizing prevention through collaboration, awareness, and innovative ...

The company, which recently completed dosing TN-201 in an initial cohort of patients in the Phase Ib/II trial, will advance the study to the next dosing cohort.

Recent studies have highlighted the unique clinical characteristics and postoperative outcomes of elderly patients undergoing ...

A 46-year-old woman attended our emergency department reporting a 3-month history of dyspnoea and, in the last 2 weeks, lower limb oedema. The patient had a history of rheumatoid arthritis, which had ...

TN-201 is being developed for the potential treatment of MYBPC3-associated hypertrophic cardiomyopathy (HCM), a condition caused by insufficient levels of myosin-binding protein C (MyBP-C). TN-201 ...

TN-201 is being developed for the potential treatment of MYBPC3-associated hypertrophic cardiomyopathy (HCM), a condition ...